The funder had no role in the study design, collection, analysis or interpretation of data, writing of the report, or decision to submit the article for publication
While we anticipate retatrutide being a strong option for many people seeking weight loss, it may be particularly useful for anyone who falls into one or more of these categories: Didnt respond to earlier GLP-1 drugs like Wegovy, Ozempic, Rybelsus, Liraglutide, Zepbound, Mounjaro, etc Plateaued with other GLP-1s but still havent met your target weight Have a large body percentage of weight to lose (20% or more) Retatrutide is currently undergoing clinical trials necessary for it to obtain FDA approval (which is anticipated by summer) , so it's not yet available to be prescribed
It can promote insulin resistance, meaning your cells become less responsive to insulin and blood sugar levels may rise
Gut Microbiota Regulate Motor Deficits and Neuroinflammation in a Model of Parkinsons Disease
Effects of nutrition intervention on total and cancer mortality: 25-year post-trial follow-up of the 5.25-year Linxian Nutrition Intervention Trial
